DHC vs WELL: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. DHC and WELL share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined DHC and WELL exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Diversified Healthcare Trust is a real estate investment trust that owns a roughly $6.2 billion portfolio of about 285 properties across 33 states and Washington, D.C. Its assets split into two main buckets: a senior housing operating portfolio (SHOP, roughly 23,900 senior living units) and medical office plus life science space (about 5.6 million square feet leased to roughly 250 tenants). DHC is externally managed by The RMR Group (Nasdaq: RMR), a commercial real estate asset manager with over $37 billion under management, so DHC has no employees of its own and pays management fees to RMR.

Full DHC guide

Welltower Inc. is the largest healthcare REIT in the world, owning a portfolio of senior housing, assisted living, post-acute and long-term care, and outpatient medical real estate across the United States, the United Kingdom, and Canada. It makes money in two main ways: through its Senior Housing Operating Portfolio (SHOP), where it shares directly in the net operating income that property operators generate from residents, and through rents on triple-net leased seniors housing and care facilities plus outpatient medical buildings. Because SHOP income flows through to Welltower rather than being fixed rent, rising occupancy and room rates translate quickly into higher earnings, which is why the operating portfolio has become the company's main growth engine.

Full WELL guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• DHC drivers: Senior housing (SHOP) recovery; Deleveraging and maturity runway.
• WELL drivers: Aging-demographics senior-housing tailwind; Operating-portfolio NOI growth.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: DHC is a leveraged small-cap REIT and remains higher risk than large diversified peers. For WELL, welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick DHC if you believe its drivers more; WELL if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the DHC and WELL guides.

DHC. DHC is a small-cap REIT best measured on FFO and NOI rather than net income, since large non-cash items (depreciation, impairments, gains on sales) swing reported earnings. Annualizing the second quarter's $0.16 of normalized FFO against a share price near $7.65 gives roughly 12x, cheap versus larger healthcare REITs, which reflects leverage still above 7x EBITDAre and recovery risk. Third-quarter results are due in early November 2026 (call scheduled for November 3), with consensus revenue near $369 million; the near-zero common dividend means valuation rests on the balance sheet and NOI trajectory, not yield.

WELL. Healthcare REITs are valued on funds from operations (FFO) rather than EPS, because standard net income is weighed down by large non-cash depreciation charges on real estate; that is why Welltower's GAAP P/E near 106x looks extreme. The key operating metric is senior-housing same-store NOI growth, now expected around 19% for 2026. At about $170 billion and a 1.45% yield, Welltower still carries a notably higher multiple than most healthcare REIT peers, and that premium is part of the investment case and part of the risk.

Headline figures (approximate, October 2026): DHC shows revenue (ttm) ~$1.5B; Q2 2026 ~$365.4M (-4.5% year over year), net loss (ttm) ~$266M (Q2 2026 ~$37.4M, -$0.10/sh vs -$0.16 est.), normalized ffo (q2 2026) ~$39M ($0.16/sh), shop same-property noi (q2 2026) ~$52M, +37.2%; occupancy ~83.1%; WELL shows revenue (ttm) ~$12.8 billion; Q2 2026 ~$3.54 billion, up ~39% YoY, net income (ttm) ~$1.55 billion GAAP (EPS ~$2.23), normalized ffo per share (2025) $5.29 (+~22.5%), 2026 senior-housing same-store noi growth ~19% expected after a raised outlook (original range 15% to 21%).

DHC and WELL are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined DHC and WELL exposure against your real portfolio. It is not an investment adviser.